← FDA Drug Approvals (Drugs@FDA)

CASPOFUNGIN ACETATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2018-07-12

Drug application

FDA Application #

ANDA209489

Application type

Abbreviated New Drug Application (Generic)

Brand name

CASPOFUNGIN ACETATE

Generic name

Caspofungin Acetate

Active ingredients

CASPOFUNGIN ACETATE

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

CIPLA

First approval

2018-07-12

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown